By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hydra Biosciences, Inc. 

790 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-5230 Fax: 617-494-5245


SEARCH JOBS




Collaborations

Cubist Pharmaceuticals, Inc. 





Company News
Hydra Biosciences, Inc. And Boehringer Ingelheim Corporation Announce Worldwide Collaboration To Develop Small-Molecule Inhibitors For The Treatment Of Central Nervous System Diseases And Disorders 4/24/2014 9:54:14 AM
Cubist Pharmaceuticals, Inc. (CBST) and Hydra Biosciences, Inc. Announce Plans to Begin Phase 1 Clinical Trial for Novel TRPA1 Modulator to Treat Acute Pain 1/10/2012 6:26:37 AM
Hydra Biosciences, Inc. and Cubist Pharmaceuticals, Inc. (CBST) Form Collaboration to Develop Novel Ion Channel Drugs for Pain Management 10/19/2009 8:43:13 AM
Research published in PNAS by Hydra Biosciences, Inc. is First Demonstration in Mammals that TRP Ion Channel Drug Can Treat Allergy-Induced Asthma 5/19/2009 10:00:12 AM
Hydra Biosciences, Inc. Raises $22 Million in Series D Financing 1/16/2009 6:46:30 AM
Hydra Biosciences, Inc. Bolsters Discovery and IP Capabilities with Key Additions to Executive Management Team 10/24/2008 8:43:45 AM
Hydra Biosciences, Inc. Raises $34M in Venture Capital 3/14/2008 12:15:34 PM
Hydra Biosciences, Inc. Announces Data Revealing the Crucial Role Played by the TRPA1 Ion Channel in a Standard Model of Pain Receptor Activation 8/7/2007 1:27:20 PM
Hydra Biosciences, Inc. Appoints Russell H. Herndon As Chief Executive Officer 1/5/2006 2:28:09 PM
Weber Shandwick Worldwide Release: Biotechnology And Pharmaceutical Executives From New England's Top Companies To Attend The Second Annual Convergence - The Life Sciences Leaders Forum10/19/2005 5:13:16 PM
12
//-->